2004
DOI: 10.1007/s11892-004-0010-z
|View full text |Cite
|
Sign up to set email alerts
|

Hyperglycemia with antipsychotic treatment

Abstract: Diabetes and mental disorders are common chronic illnesses in the United States. Recently, the introduction of a new class of atypical antipsychotic medications has been a major treatment advance for patients with mental disorders. Because of increased use of atypical antipsychotic medications, new and unanticipated side effects have often appeared. Treatment-emergent diabetes has been described for conventional and atypical antipsychotics. People with schizophrenia may be at increased risk for type 2 diabetes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2006
2006
2008
2008

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 61 publications
(46 reference statements)
0
3
0
Order By: Relevance
“…In the past decade there has been a growing concern among clinicians and researchers that use of AAPs may be related to potentially serious adverse metabolic effects, including weight gain, hyperlipidemia and glucose intolerance (Koller et al, 2001;Allison and Casey, 2001;Wirshing et al, 2002;Koller and Doraiswamy, 2002;Meyer, 2002;Jin et al, 2002;Koller et al, 2003;Koller et al, 2004;Jin et al, 2004;Meyer and Koro, 2004;Sathyaprakash and Henry, 2004;Newcomer, 2005). Clinical studies indicate that certain antipsychotics carry a high risk of treatment-related metabolic dysfunction (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…In the past decade there has been a growing concern among clinicians and researchers that use of AAPs may be related to potentially serious adverse metabolic effects, including weight gain, hyperlipidemia and glucose intolerance (Koller et al, 2001;Allison and Casey, 2001;Wirshing et al, 2002;Koller and Doraiswamy, 2002;Meyer, 2002;Jin et al, 2002;Koller et al, 2003;Koller et al, 2004;Jin et al, 2004;Meyer and Koro, 2004;Sathyaprakash and Henry, 2004;Newcomer, 2005). Clinical studies indicate that certain antipsychotics carry a high risk of treatment-related metabolic dysfunction (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…, and diabetes (Sathyaprakash and Henry 2004). Moreover, D2 antagonists are generally ineffective in treating negative symptoms and cognitive deficits associated with schizophrenia (Miyamoto et al 2005).…”
mentioning
confidence: 99%
“…Because of this, when we examine the Cauchy convergence involving the x 7 approximation we will use the super-diagonal P-approximant as our template. In this work we will use the projected third-generation EURO noise curve in our overlap calculations as it has the greatest sensitivity [35].…”
Section: The Cauchy Convergence Of T-and P-approximant Templatesmentioning
confidence: 99%